Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19)
10.5847/wjem.j.1920-8642.2020.03.013
- Author:
Giuseppe Lippi
- Publication Type:Letter
- Keywords:
COVID-19
- From:
World Journal of Emergency Medicine
2020;11(3):193-194
- CountryChina
- Language:English
-
Abstract:
A recent study based on the use of experimental
artificial intelligence (AI) tool showed 70%–80%
accuracy in predicting development of severe disease
in coronavirus disease 2019 (COVID-19) based on
predictive parameters alanine aminotransferase (ALT),
myalgia and hemoglobin, whilst only 5 of 53 patients
developed acute respiratory distress syndrome (ARDS),
2 of whom reporting myalgia.[1] It is commonly
advocated that myalgia may reflect generalized
inflammation and cytokine response.[1] Multiple studies
showed that myalgia is a common symptom at onset
of COVID-19, seen in up to 36% of such patients.[2]
Therefore, in this short article we aim to further assess
whether myalgia may be a reliable predictor of severe
COVID-19 disease.